[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@LPessa7654 personofinterestpersonofinterest posts on X about $imrx, $rvmd, $15b, $03b the most. They currently have XX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Social topic influence $imrx #1, $rvmd #4, $15b 5.88%, $03b 5.88%, $02b XXXX%
Top accounts mentioned or mentioned by @aditharun @nachotrust @bananaoncology @andreagtc @quantumup1 @houndcl @randombiothinks @skipperdoodle3 @aditharun_ @investingcom @kjerath @mainz058 @george42600360 @ashton1nvests @banana_oncology
Top assets mentioned Revolution Medicines, Inc. Common Stock (RVMD)
Top posts by engagements in the last XX hours
"@aditharun_ @Banana_Oncology @houndcl Since $rvmd drug requires a KRAS mutation while $IMRX doesnt is there any reason these treatments couldnt coexist in the first-line setting"
X Link 2025-12-11T18:02Z XX followers, XXX engagements
"@aditharun_ isnt $rvmd Ph3 for 2L only my understanding was that for 1l patients only $imrx was entering Ph3"
X Link 2025-12-09T23:13Z XX followers, XXX engagements
"@aditharun_ but still early trials while $imrx is starting phase X right"
X Link 2025-12-10T03:56Z XX followers, XXX engagements
"@Banana_Oncology @aditharun_ @houndcl I believe the other question is with such an uncertain outcome if a $15b valuation of $rvmd vs $0.3b (with $0.2b in cash) of $imrx is justified"
X Link 2025-12-11T14:41Z XX followers, XXX engagements
"@aditharun_ @Banana_Oncology @houndcl doesnt seem like a winner takes all"
X Link 2025-12-11T18:05Z XX followers, XX engagements